Abstract |
For hepatocarcinoma (HCC) gene therapy, the tumoricidal efficacy and selective expression of therapeutic gene remain two major challenges. The Escherichia coli (E. coli) purine nucleoside phosphorylase (PNP)/9-(2-deoxy-beta-dribofuranosyl)-6-methylpurine (MeP-dR) suicide gene system exhibits excellent anti- tumor effects, indicating this system directed by a HCC-specific promoter would offer a possibility of targeting gene therapy for HCC. To test this hypothesis, here, we prepared a plasmid (p[HRE]AF/PNP) containing the E. coli PNP/MeP-dR system and a chimeric human alpha-fetoprotein (AFP) promoter, [HRE]AF. We introduced this plasmid into AFP-positive and low-AFP-generating human HCC cells, and evaluated its therapeutic effects on both human HCC cell lines. In the presence of hypoxia, the E. coli PNP gene directed by the [HRE]AF promoter were HCC-specifically expressed in two human HCC cell lines and, moreover, the [HRE]AF-PNP/MeP-dR therapy would yield significant and selective cytotoxicity in both AFP-positive and low-AFP-generating HCC cells. Our findings suggest the [HRE]AF-PNP/MeP-dR therapy has worthy potentialities as an effective strategy for targeting therapy of AFP-positive, and especially AFP-negative or low-AFP-generating HCC.
|
Authors | Xiaokun Cai, Junli Zhou, Ying Chang, Xuemei Sun, Peiyuan Li, Junsheng Lin |
Journal | Cancer letters
(Cancer Lett)
Vol. 264
Issue 1
Pg. 71-82
(Jun 08 2008)
ISSN: 0304-3835 [Print] Ireland |
PMID | 18407409
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- RNA, Messenger
- Recombinant Proteins
- alpha-Fetoproteins
- Purine-Nucleoside Phosphorylase
|
Topics |
- Apoptosis
(drug effects, genetics)
- Bystander Effect
- Carcinoma, Hepatocellular
(genetics, metabolism, therapy)
- Cell Hypoxia
- Cell Line, Tumor
- Escherichia coli
(enzymology, genetics)
- Gene Targeting
- Genes, Transgenic, Suicide
(genetics)
- Genetic Therapy
(methods)
- Genetic Vectors
- HeLa Cells
- Humans
- Liver Neoplasms
(genetics, metabolism, therapy)
- Plasmids
- Promoter Regions, Genetic
- Purine-Nucleoside Phosphorylase
(genetics)
- RNA, Messenger
(biosynthesis)
- Recombinant Proteins
(genetics)
- alpha-Fetoproteins
(biosynthesis, genetics)
|